Weight-Loss Drugs Influence Swimwear Spending Trends
Circana's latest research highlights a notable trend in wardrobe spending linked to weight-loss drugs, particularly GLP-1 receptor agonists. These medications, used for treating conditions such as type 2 diabetes and obesity, are reshaping consumer spending patterns, with swimwear emerging as a key category. According to the findings, spending on swimwear has increased significantly in the second year of treatment, marking a shift in how consumers approach their fashion choices.
In the report titled "GLP-1 Unlocked: The Next Phase of Consumer and Retail Transformation," Circana reveals that swimwear's spending index was 15.5 points above its pre-treatment baseline in year two, a substantial increase from just 1.7 points in year one. This trend is mirrored in outerwear, which saw its spending index rise from 10.9 points to 15 points over the same period. The data suggests that as consumers experience changes in their body size and shape, they are more inclined to invest in new swimwear and outerwear, reflecting a desire to update their wardrobes.
The research is based on an analysis of US household purchases from August 2023 to July 2026, focusing on households with at least one current GLP-1 user who began treatment between 2024 and 2026. This analysis compares their spending patterns to those of households that have never used these medications, providing valuable insights into the impact of weight-loss treatments on consumer behavior.
Circana's methodology accounts for various market influences, including inflation and seasonality, ensuring a comprehensive understanding of spending trends. The findings indicate that while swimwear and outerwear are gaining traction, other categories such as accessories and jewelry are experiencing declines. Specifically, accessory spending fell from 1.2 points below baseline in year one to 2.5 points below in year two, while jewelry saw a sharper decline from 7.6 to 12.3 points below baseline.
Impact of Weight-Loss Drugs on Fashion Choices
Interestingly, the report also highlights that 43 percent of households with a current GLP-1 user reported purchasing clothing or footwear in the previous three months due to their treatment. The most common motivations for these purchases included size changes (28 percent), updating personal style (18 percent), and engaging in new activities (13 percent). This indicates that the influence of weight-loss drugs extends beyond mere size adjustments, prompting consumers to rethink their fashion choices and invest in new styles.
Latest Trends
As the apparel industry adapts to these changes, Circana suggests that businesses may need to consider more responsive size planning and fit guidance. Additionally, offering options for size exchanges and transitional wardrobes could cater to consumers navigating changes in their body sizes. Rental and resale markets may also present opportunities for retailers to accommodate customers who are fluctuating between sizes without requiring a complete wardrobe overhaul.
Overall, the findings from Circana shed light on the evolving relationship between weight-loss treatments and fashion spending, particularly in the swimwear and outerwear categories. As consumers embrace new styles and sizes, retailers must remain agile and responsive to these shifting demands to capture the growing market of fashion-conscious individuals influenced by their health journeys.
